BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21814507)

  • 61. Opportunities and Challenges in Activity-Based Protein Profiling of Mycobacteria.
    Patel HV; Li M; Seeliger JC
    Curr Top Microbiol Immunol; 2019; 420():49-72. PubMed ID: 30178262
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PE and PPE Genes: A Tale of Conservation and Diversity.
    Delogu G; Brennan MJ; Manganelli R
    Adv Exp Med Biol; 2017; 1019():191-207. PubMed ID: 29116636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ins and outs of Mycobacterium tuberculosis PPE family in pathogenesis and implications for novel measures against tuberculosis.
    Deng W; Xie J
    J Cell Biochem; 2012 Apr; 113(4):1087-95. PubMed ID: 22275049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlation of drug resistance with single nucleotide variations through genome analysis and experimental validation in a multi-drug resistant clinical isolate of M. tuberculosis.
    Bhattacharyya K; Nemaysh V; Joon M; Pratap R; Varma-Basil M; Bose M; Brahmachari V
    BMC Microbiol; 2020 Jul; 20(1):223. PubMed ID: 32711461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Uncovering new signaling proteins and potential drug targets through the interactome analysis of Mycobacterium tuberculosis.
    Cui T; Zhang L; Wang X; He ZG
    BMC Genomics; 2009 Mar; 10():118. PubMed ID: 19298676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Mycobacterium tuberculosis drugome and its polypharmacological implications.
    Kinnings SL; Xie L; Fung KH; Jackson RM; Xie L; Bourne PE
    PLoS Comput Biol; 2010 Nov; 6(11):e1000976. PubMed ID: 21079673
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Mycobacterium tuberculosis Ser/Thr kinase substrate Rv2175c is a DNA-binding protein regulated by phosphorylation.
    Cohen-Gonsaud M; Barthe P; Canova MJ; Stagier-Simon C; Kremer L; Roumestand C; Molle V
    J Biol Chem; 2009 Jul; 284(29):19290-300. PubMed ID: 19457863
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis.
    Mustyala KK; Malkhed V; Chittireddy VR; Vuruputuri U
    Int J Mycobacteriol; 2015 Dec; 4(4):330-6. PubMed ID: 26964817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mycobacterium tuberculosis Resists Stress by Regulating PE19 Expression.
    Ramakrishnan P; Aagesen AM; McKinney JD; Tischler AD
    Infect Immun; 2015 Dec; 84(3):735-46. PubMed ID: 26712204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis.
    Zumbo A; Palucci I; Cascioferro A; Sali M; Ventura M; D'Alfonso P; Iantomasi R; Di Sante G; Ria F; Sanguinetti M; Fadda G; Manganelli R; Delogu G
    Pathog Dis; 2013 Dec; 69(3):232-9. PubMed ID: 24106104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mycobacterial PE_PGRS proteins contain calcium-binding motifs with parallel beta-roll folds.
    Bachhawat N; Singh B
    Genomics Proteomics Bioinformatics; 2007 Dec; 5(3-4):236-41. PubMed ID: 18267304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Study of interactions between Mycobacterium tuberculosis proteins: SigK and anti-SigK.
    Malkhed V; Gudlur B; Kondagari B; Dulapalli R; Vuruputuri U
    J Mol Model; 2011 May; 17(5):1109-19. PubMed ID: 20676709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative genomic and proteomic analyses of PE/PPE multigene family of Mycobacterium tuberculosis H₃₇Rv and H₃₇Ra reveal novel and interesting differences with implications in virulence.
    Kohli S; Singh Y; Sharma K; Mittal A; Ehtesham NZ; Hasnain SE
    Nucleic Acids Res; 2012 Aug; 40(15):7113-22. PubMed ID: 22618876
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The PE multigene family: a 'molecular mantra' for mycobacteria.
    Brennan MJ; Delogu G
    Trends Microbiol; 2002 May; 10(5):246-9. PubMed ID: 11973159
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Solution structure of the Mycobacterium tuberculosis complex protein MPB70: from tuberculosis pathogenesis to inherited human corneal desease.
    Carr MD; Bloemink MJ; Dentten E; Whelan AO; Gordon SV; Kelly G; Frenkiel TA; Hewinson RG; Williamson RA
    J Biol Chem; 2003 Oct; 278(44):43736-43. PubMed ID: 12917404
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conserved hypothetical protein Rv1977 in Mycobacterium tuberculosis strains contains sequence polymorphisms and might be involved in ongoing immune evasion.
    Jiang Y; Liu H; Wang X; Li G; Qiu Y; Dou X; Wan K
    Int J Clin Exp Pathol; 2015; 8(6):6891-900. PubMed ID: 26261576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The potential impact of structural genomics on tuberculosis drug discovery.
    Arcus VL; Lott JS; Johnston JM; Baker EN
    Drug Discov Today; 2006 Jan; 11(1-2):28-34. PubMed ID: 16478688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.